CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes
Summary
An NCI protocol to identify sporadic chordoma patients for future studies of cancer-susceptibility genes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Genes, Sporadic Chordoma | Status: ACTIVE_NOT_RECRUITING